XML 74 R63.htm IDEA: XBRL DOCUMENT v3.21.2
LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS - Narrative (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 30, 2021
Jun. 26, 2021
USD ($)
Mar. 27, 2021
USD ($)
payment
Jun. 27, 2020
USD ($)
Jun. 26, 2021
USD ($)
Jun. 27, 2020
USD ($)
Dec. 26, 2020
USD ($)
Dec. 28, 2019
USD ($)
Dec. 29, 2018
USD ($)
Debt Instrument [Line Items]                  
Weighted average interest rate   2.74%     2.74%   3.11%    
Deferred financing costs expensed         $ 38,166,000 $ 0      
Debt extinguishment and financing costs         $ 27,980,000 0      
Number of consecutive fiscal quarters         1 year        
Foreign Exchange Forward                  
Debt Instrument [Line Items]                  
Derivative amount   $ 400,000,000   $ 400,000,000 $ 400,000,000 400,000,000      
Term Loans                  
Debt Instrument [Line Items]                  
Prepayments of long-term debt     $ 146,900,000            
Deferred financing costs expensed     200,000            
Credit Facility | Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Prepayments of long-term debt     135,000,000            
$750 Million Term Loan | Credit Facility                  
Debt Instrument [Line Items]                  
Credit facility     $ 750,000,000            
Number of quarterly installment payments | payment     19            
$2.05 Billion Credit Facility | Credit Facility                  
Debt Instrument [Line Items]                  
Minimum EBITDA less capital expenditures to consolidated cash interest expense ratio   3.50     3.50        
$2.05 Billion Credit Facility | Credit Facility | Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Credit facility     $ 2,050,000,000.00            
5.5% Senior Notes due 2026 | Senior Notes                  
Debt Instrument [Line Items]                  
Prepayments of long-term debt     500,000,000            
Deferred financing costs expensed     5,000,000            
Aggregate principal amount                 $ 500,000,000
Stated interest rate   5.50%     5.50%   5.50%   5.50%
Debt extinguishment and financing costs     21,000,000            
Payments for accrued interest     13,000,000            
4.25% Senior Notes due 2028 | Senior Notes                  
Debt Instrument [Line Items]                  
Maximum consolidated indebtedness to consolidated EBITDA   4.25     4.25        
Aggregate principal amount               $ 500,000,000  
Stated interest rate   4.25%     4.25%   4.25% 4.25%  
3.75% Senior Notes due 2029 | Senior Notes                  
Debt Instrument [Line Items]                  
Aggregate principal amount     $ 500,000,000            
Stated interest rate   3.75% 3.75%   3.75%   3.75%    
4.0% Senior Notes due 2031 | Senior Notes                  
Debt Instrument [Line Items]                  
Aggregate principal amount     $ 500,000,000            
Stated interest rate   4.00% 4.00%   4.00%   4.00%    
$3 Billion Credit Facility | Credit Facility | Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Credit facility   $ 3,000,000,000.0     $ 3,000,000,000.0        
$3 Billion Credit Facility | Credit Facility | Revolving Credit Facility | Federal Funds Rate                  
Debt Instrument [Line Items]                  
Variable interest rate 0.50%                
$3 Billion Credit Facility | Credit Facility | Revolving Credit Facility | LIBOR                  
Debt Instrument [Line Items]                  
Variable interest rate 1.00%                
Senior Notes Due 2029 And 2031 | Senior Notes                  
Debt Instrument [Line Items]                  
Aggregate principal amount     $ 1,000,000,000            
Debt extinguishment and financing costs     10,000,000            
Senior Notes Due 2029 And 2031 | Senior Notes | Cognate BioServices, Inc.                  
Debt Instrument [Line Items]                  
Debt extinguishment and financing costs     21,000,000            
Payments for accrued interest     $ 13,000,000            
Letter of Credit                  
Debt Instrument [Line Items]                  
Letters of credit outstanding   16,700,000     16,700,000   $ 16,000,000.0    
Other Nonoperating Income (Expense) | Foreign Exchange Forward                  
Debt Instrument [Line Items]                  
Foreign currency losses recognized         18,300,000 4,200,000      
Interest Expense | Foreign Exchange Forward                  
Debt Instrument [Line Items]                  
Recognized gains from derivatives   $ 5,355,000   $ 0 $ 19,332,000 $ 6,067,000